1. Proceedings of a Sickle Cell Disease Ontology workshop — Towards the first comprehensive ontology for Sickle Cell Disease
- Author
-
Catherine Chunda-Liyoka, Melissa A. Haendel, Sumir Panji, Kwaku Ohene-Frempong, Marsha Treadwell, Kenneth Opap, Philomene Lopez-Sall, Simon Jupp, Kofi A. Anie, Bamidele O. Tayo, Vimal K. Derebail, Kais Ghedira, Karen Kengne Kamga, Solomon F. Ofori-Acquah, Andrew D. Campbell, Raphael Z. Sangeda, Adekunle Adekile, Furahini Chinenere, Muntaser E. Ibrahim, Neil A. Hanchard, Damian Nirenberg, Deogratias Munube, Carol Hamilton, Nicola Mulder, Mamana Mbiyavanga, Biobele J. Brown, Jennifer Knight-Madden, Léon Tshilolo, Victoria Nembaware, Baba Inusa, Charmaine D.M. Royal, Miriam Park, Obiageli E Nnodu, Wayne Huggins, Ambroise Wonkam, Gift D. Pule, Amy Geard, University of Cape Town, Kuwait University, Imperial College London, Evelina London Children's Hospital, University of Ibadan, University of Michigan [Ann Arbor], University of Michigan System, University of Dar es Salaam (UDSM), University Teaching Hospital [Lusaka] (UTH), University of Zambia [Lusaka] (UNZA), University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Laboratoire de Parasitologie Médicale, Biotechnologies et Biomolécules (LR11IPT06), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Research Triangle Institute International (RTI International), Baylor College of Medicine (BCM), Baylor University, Oregon Health and Science University [Portland] (OHSU), University of Khartoum, European Bioinformatics Institute [Hinxton] (EMBL-EBI), EMBL Heidelberg, University of Yaoundé [Cameroun], The University of the West Indies, Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD), Makerere University College of Health Science [Kampala] (CHS), Makerere University [Kampala, Ouganda] (MAK), University of Abuja, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), Children’s Hospital of Philadelphia (CHOP ), University of São Paulo (USP), Duke University [Durham], Loyola University [Chicago], UCSF Benioff Children's Hospital Oakland, University of California [San Francisco] (UCSF), University of California-University of California, Centre de formation et d’appui sanitaire de Monkole (CEFA-MONKOLE), The workshop was funded by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) as a supplement to the H3ABioNet grant. H3ABioNet is supported by the National Human Genome Research Institute (NHGRI), Office of the Director (OD), NIH under award number U41HG006941. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funding for two of the participants was provided by the National Human Genome Research Institute and the National Institute on Drug Abuse Genomic Resource Award: U41 HG007050 and the National Heart, Lung, and Blood Institute Supplement: U41HG007050-02S4., and We would like to thank Jade Hotchkiss who started the initial work on the ontology.
- Subjects
0301 basic medicine ,medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,lcsh:QH426-470 ,[SDV]Life Sciences [q-bio] ,Pharmaceutical Science ,Single gene ,Disease ,Ontology (information science) ,Bioinformatics ,Article ,03 medical and health sciences ,Quality of life (healthcare) ,Rare Diseases ,Disease Ontology ,hemic and lymphatic diseases ,medicine ,Intensive care medicine ,Molecular Biology ,Pediatric ,Sickle Cell Disease ,business.industry ,Pain Research ,Hematology ,3. Good health ,lcsh:Genetics ,030104 developmental biology ,Orphan Drug ,Good Health and Well Being ,business ,Biotechnology - Abstract
International audience; Sickle cell disease (SCD) is a debilitating single gene disorder caused by a single point mutation that results in physical deformation (i.e. sickling) of erythrocytes at reduced oxygen tensions. Up to 75% of SCD in newborns world-wide occurs in sub-Saharan Africa, where neonatal and childhood mortality from sickle cell related complications is high. While SCD research across the globe is tackling the disease on multiple fronts, advances have yet to significantly impact on the health and quality of life of SCD patients, due to lack of coordination of these disparate efforts. Ensuring data across studies is directly comparable through standardization is a necessary step towards realizing this goal. Such a standardization requires the development and implementation of a disease-specific ontology for SCD that is applicable globally. Ontology development is best achieved by bringing together experts in the domain to contribute their knowledge.The SCD community and H3ABioNet members joined forces at a recent SCD Ontology workshop to develop an ontology covering aspects of SCD under the classes: phenotype, diagnostics, therapeutics, quality of life, disease modifiers and disease stage. The aim of the workshop was for participants to contribute their expertise to development of the structure and contents of the SCD ontology. Here we describe the proceedings of the Sickle Cell Disease Ontology Workshop held in Cape Town South Africa in February 2016 and its outcomes. The objective of the workshop was to bring together experts in SCD from around the world to contribute their expertise to the development of various aspects of the SCD ontology.
- Published
- 2016
- Full Text
- View/download PDF